GENEVA, Aug. 3 -- APOTEX INC (150 Signet DriveToronto, Ontario M9L1T9) filed a patent application (PCT/CA2025/050085) for "CRYSTALLINE FORMS OF OZANIMOD HYDROCHLORIDE" on Jan 23, 2025. With publication no. WO/2025/156044, the details related to the patent application was published on Jul 31, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): PRICE, Jeffrey S. (c/o Apotex Pharmachem Inc., Station Main, P.O. Box 1976Brantford, Ontario N3T5W5), SOUZA, Fabio E.S. (c/o Apotex Pharmachem Inc.Station Main P.O. Box 1976Brantford, Ontario N3T 5W5), REY, Allan W. (c/o Apotex Pharmachem Inc.Station Main P...